1. Home
  2. NOTV vs KNDI Comparison

NOTV vs KNDI Comparison

Compare NOTV & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • KNDI
  • Stock Information
  • Founded
  • NOTV 1974
  • KNDI 2002
  • Country
  • NOTV United States
  • KNDI China
  • Employees
  • NOTV N/A
  • KNDI N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • KNDI Auto Manufacturing
  • Sector
  • NOTV Health Care
  • KNDI Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • KNDI Nasdaq
  • Market Cap
  • NOTV 137.5M
  • KNDI 112.8M
  • IPO Year
  • NOTV 1997
  • KNDI N/A
  • Fundamental
  • Price
  • NOTV $1.64
  • KNDI $1.16
  • Analyst Decision
  • NOTV Strong Buy
  • KNDI
  • Analyst Count
  • NOTV 3
  • KNDI 0
  • Target Price
  • NOTV $5.92
  • KNDI N/A
  • AVG Volume (30 Days)
  • NOTV 1.2M
  • KNDI 133.5K
  • Earning Date
  • NOTV 05-09-2025
  • KNDI 05-15-2025
  • Dividend Yield
  • NOTV N/A
  • KNDI N/A
  • EPS Growth
  • NOTV N/A
  • KNDI N/A
  • EPS
  • NOTV N/A
  • KNDI N/A
  • Revenue
  • NOTV $475,114,000.00
  • KNDI $118,127,232.00
  • Revenue This Year
  • NOTV $6.07
  • KNDI N/A
  • Revenue Next Year
  • NOTV $5.74
  • KNDI N/A
  • P/E Ratio
  • NOTV N/A
  • KNDI N/A
  • Revenue Growth
  • NOTV N/A
  • KNDI N/A
  • 52 Week Low
  • NOTV $1.15
  • KNDI $0.89
  • 52 Week High
  • NOTV $6.48
  • KNDI $2.98
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 38.13
  • KNDI 37.20
  • Support Level
  • NOTV $1.15
  • KNDI $1.15
  • Resistance Level
  • NOTV $1.85
  • KNDI $1.27
  • Average True Range (ATR)
  • NOTV 0.44
  • KNDI 0.09
  • MACD
  • NOTV -0.05
  • KNDI -0.02
  • Stochastic Oscillator
  • NOTV 28.16
  • KNDI 6.06

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in the development, production, and distribution of electric vehicle (EV) products, EV parts, and off-road vehicle products in the Chinese market. Other product offerings include all-terrain vehicles, go-karts, utility vehicles, battery packs, and other systems. It generates maximum revenue through off-road vehicles. The company generates the majority of its revenue from the United states along with other Countries, followed by China.

Share on Social Networks: